Espada, Caroline Ricce 
; Wendt, Andreia Albuquerque ; Hornillos, Valentín ; Gluenz, Eva ; Coelho, Adriano Cappellazzo ; Uliana, Silvia Reni Bortolin
Source: ACS Infectious Diseases. Unidade: ICB
Subjects: PARASITOLOGIA, LEISHMANIA BRASILIENSIS, RESISTÊNCIA MICROBIANA ÀS DROGAS, ANTIPARASITÁRIOS, PREDISPOSIÇÃO GENÉTICA PARA DOENÇA, MICRORNAS, PROTEINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ESPADA, Caroline Ricce et al. Ros3 (Lem3p/CDC50) gene dosage is implicated in miltefosine susceptibility in Leishmania (Viannia) braziliensis clinical isolates and in Leishmania (Leishmania) major. ACS Infectious Diseases, v. 7, n. 4, p. 849–858, 2021Tradução . . Disponível em: https://doi.org/10.1021/acsinfecdis.0c00857. Acesso em: 10 nov. 2024.APA
Espada, C. R., Wendt, A. A., Hornillos, V., Gluenz, E., Coelho, A. C., & Uliana, S. R. B. (2021). Ros3 (Lem3p/CDC50) gene dosage is implicated in miltefosine susceptibility in Leishmania (Viannia) braziliensis clinical isolates and in Leishmania (Leishmania) major. ACS Infectious Diseases, 7( 4), 849–858. doi:10.1021/acsinfecdis.0c00857NLM
Espada CR, Wendt AA, Hornillos V, Gluenz E, Coelho AC, Uliana SRB. Ros3 (Lem3p/CDC50) gene dosage is implicated in miltefosine susceptibility in Leishmania (Viannia) braziliensis clinical isolates and in Leishmania (Leishmania) major [Internet]. ACS Infectious Diseases. 2021 ; 7( 4): 849–858.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1021/acsinfecdis.0c00857Vancouver
Espada CR, Wendt AA, Hornillos V, Gluenz E, Coelho AC, Uliana SRB. Ros3 (Lem3p/CDC50) gene dosage is implicated in miltefosine susceptibility in Leishmania (Viannia) braziliensis clinical isolates and in Leishmania (Leishmania) major [Internet]. ACS Infectious Diseases. 2021 ; 7( 4): 849–858.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1021/acsinfecdis.0c00857
